RISE: A single and repeat dosing study of the safety, drug exposure, and clinical activity of R-3750 in patients with mild to moderate ulcerative colitis
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Digestive Health and Surgery -
Location
-
Principal Investigator
Jennifer Seminerio-Diehl -
Sponsor
Rise Therapeutics LLC
The purpose of this study is to determine if R-3750 DP is safe and to determine how much R-3750 DP (what dosage) to give to people with UC.
Enrollment Form
This study is currently enrolling.